Company: PTPI
Filing Date: 2025-03-07
Form Type: PRE 14A
Source: 0001104659-25-021794
Chunk: 26

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-07
Form: PRE 14A
Chunk 26
---
 property which
the holders would have received had they exercised the Series A Warrants immediately prior to such fundamental transaction. Any successor
to us or surviving entity shall assume the obligations under the Series A Warrants. Additionally, as more fully described in the
Series A Warrants, in the event of certain fundamental transactions, the holders of the Series A Warrants will be entitled to
receive consideration in an amount equal to the Black Scholes value of such Series A Warrants on the date of consummation of such
transaction.

Any reduction to the exercise prices of the Series A Warrants
and resulting increase in the number of shares of Common Stock underlying the Warrants will be subject to the Series A Floor Price then
in effect.

Transferability

Subject to applicable laws, a Series A Warrant
may be transferred at the option of the holder upon surrender of the Series A Warrant to us together with the appropriate instruments
of transfer.

Fractional Shares

No fractional shares of Common Stock will be issued upon the exercise
of the Series A Warrants. Rather, the number of shares of Common Stock to be issued will, at our election, either be rounded up to
the next whole share or we will pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the exercise price.

<div align='center'>17</div>

Trading Market

There is no established trading market for the
Series A Warrants, and we do not expect an active trading market to develop. We do not intend to apply to list the Series A
Warrants on any securities exchange or other trading market. Without a trading market, the liquidity of the Series A Warrants will
be extremely limited.

Right as a Stockholder

Except as otherwise provided in the Series A Warrants or by virtue
of such holder’s ownership of our shares of Common Stock, the holder of a Series A Warrant does not have the rights or privileges
of a holder of our Common Stock, including any voting rights, until the holder exercises the Series A Warrant.

Waivers and Amendments

The Series A Warrants may be modified or
amended, or the provisions thereof waived with the written consent of the Company and the respective holder.

Series B Warrants

The following summary of certain terms and provisions of the Series B Warrants is not complete and is subject to, and qualified in its entirety by, the provisions of the Series A Warrant, the form of which was filed as an exhibit to the Current Report